Shaun Cote

441 total citations
14 papers, 313 citations indexed

About

Shaun Cote is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shaun Cote has authored 14 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shaun Cote's work include Muscle Physiology and Disorders (7 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cardiomyopathy and Myosin Studies (4 papers). Shaun Cote is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cardiomyopathy and Myosin Studies (4 papers). Shaun Cote collaborates with scholars based in United States, United Kingdom and Canada. Shaun Cote's co-authors include Adrian Whitty, Eric S. Day, Raymond Lahaie, Arun Sahai, David Gianfelice, Manon Bélair, Kimberly Long, Joseph P. Stains, Adriana Donovan and Sergey Paushkin and has published in prestigious journals such as Journal of the American Chemical Society, Neurology and Biochemistry.

In The Last Decade

Shaun Cote

14 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaun Cote United States	8	193	105	93	50	31	14	313
Michael Košťál Slovakia	7	214 1.1×	18 0.2×	53 0.6×	28 0.6×	23 0.7×	13	431
Magnus Althage Sweden	11	204 1.1×	25 0.2×	69 0.7×	56 1.1×	2 0.1×	23	371
Eva H. N. Olsen United States	11	93 0.5×	47 0.4×	25 0.3×	24 0.5×	4 0.1×	15	281
Audrey Turchick United States	8	124 0.6×	27 0.3×	11 0.1×	10 0.2×	17 0.5×	12	266
Martin Špaček Czechia	9	74 0.4×	72 0.7×	10 0.1×	13 0.3×	5 0.2×	47	267
Matthew Martin United States	13	343 1.8×	16 0.2×	19 0.2×	17 0.3×	8 0.3×	30	497
Sara Calzavarini Switzerland	10	176 0.9×	88 0.8×	36 0.4×	4 0.1×	3 0.1×	18	470
Pengcheng Shi China	12	155 0.8×	10 0.1×	18 0.2×	12 0.2×	15 0.5×	33	329
Toshiya Nomura Japan	10	212 1.1×	13 0.1×	25 0.3×	52 1.0×	5 0.2×	35	355
Marco Gigante Italy	10	78 0.4×	55 0.5×	46 0.5×	7 0.1×	6 0.2×	28	306

Countries citing papers authored by Shaun Cote

Since Specialization

Citations

This map shows the geographic impact of Shaun Cote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaun Cote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaun Cote more than expected).

Fields of papers citing papers by Shaun Cote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaun Cote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaun Cote. The network helps show where Shaun Cote may publish in the future.

Co-authorship network of co-authors of Shaun Cote

This figure shows the co-authorship network connecting the top 25 collaborators of Shaun Cote. A scholar is included among the top collaborators of Shaun Cote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaun Cote. Shaun Cote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2024). Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3. Neurology. 102(5). e209151–e209151. 19 indexed citations

Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2022). Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (P15-5.005). Neurology. 98(18_supplement). 2 indexed citations

Barrett, D, Sanela Bilic, Yung Chyung, et al.. (2021). A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. Advances in Therapy. 38(6). 3203–3222. 30 indexed citations

Yap, Timothy A., Minal Barve, Justin F. Gainor, et al.. (2021). 532 First-in-human phase 1 trial of SRK-181: a latent TGFβ1 inhibitor, alone or in combination with anti-PD-(L)1 treatment in patients with advanced solid tumors (DRAGON trial). Regular and Young Investigator Award Abstracts. A563–A563. 3 indexed citations

Welsh, Brian T., et al.. (2021). Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease. International Journal of Toxicology. 40(4). 322–336. 9 indexed citations

Barrett, D, Shaun Cote, George G. Nomikos, et al.. (2021). SMA - TREATMENT. Neuromuscular Disorders. 31. S134–S134. 1 indexed citations

Cote, Shaun, Justin Jackson, Michelle Pirruccello, Gregory J. Carven, & Stefan Wawersik. (2019). A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation. SLAS DISCOVERY. 25(1). 95–103. 5 indexed citations

Kalra, Ashish, Shaun Cote, D Barrett, et al.. (2019). P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans. Neuromuscular Disorders. 29. S85–S85. 3 indexed citations

Long, Kimberly, Karen M. O’Shea, Ramzi J. Khairallah, et al.. (2018). Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy. Human Molecular Genetics. 28(7). 1076–1089. 82 indexed citations

10.

Cote, Shaun, et al.. (2013). Mutation of Nonessential Cysteines Shows That the NF-κB Essential Modulator Forms a Constitutive Noncovalent Dimer That Binds IκB Kinase-β with High Affinity. Biochemistry. 52(51). 9141–9154. 15 indexed citations

11.

Cote, Shaun, Brandon S. Zerbe, Dmitri Beglov, et al.. (2013). Comprehensive Experimental and Computational Analysis of Binding Energy Hot Spots at the NF-κB Essential Modulator/IKKβ Protein–Protein Interface. Journal of the American Chemical Society. 135(16). 6242–6256. 39 indexed citations

12.

Day, Eric S., Shaun Cote, & Adrian Whitty. (2012). Binding Efficiency of Protein–Protein Complexes. Biochemistry. 51(45). 9124–9136. 37 indexed citations

13.

Cote, Shaun, et al.. (2010). Synthesis and application of organomercury haptens for enzyme-linked immunoassay of inorganic and organic mercury. Analytical Biochemistry. 404(2). 179–185. 5 indexed citations

14.

Sahai, Arun, et al.. (1997). Percutaneous drainage of intra-abdominal abscesses in Crohn's disease: short and long-term outcome.. PubMed. 92(2). 275–8. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact